The placebo rate was 33% versus 70% anticipated, limiting statistical power; larger studies may further assess protection ...

The Centre Chakhesang Youth Organisation (CCYO) on Monday launched the second phase of its indefinite agitation by picketing three Forest department offices in Phek district over the government’s ...

Kohima, Oct 12 (PTI) The Chozuba Circle Youth Organisation (CCYO) on Monday launched the second phase of its indefinite agitation by picketing three forest offices in Nagaland's Phek district over the ...

Detailed analysis from the randomized, double-blind, placebo-controlled Phase 3 TRIUMpH-NERD study demonstrated that both ...

From implementation to adoptionAs of October 2026, the use of generative AI in companies has reached a clear turning point.

Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading clinical-stage biopharmaceutical company focused on cardiometabolic diseases, ...

Annie Thurman, MD, FACOG, Medical Director of Daré Bioscience, will present “An Open-Label, Single-Dose, Randomized, Parallel-Cohort Study of the Safety and Relative Bioavailability of Topical ...

The FDA-aligned pivotal efficacy population includes 12 male patients receiving commercial-grade RP-A501 at the recalibrated dose. The first three patients treated under the modified protocol count ...

Vaults are where onchain capital is heading. Curated vault assets have grown 39% over the past year and users have deposited more than $10 billion into Morpho in the last two years, around $1 billion ...

The CCYO stated that it is therefore compelled to take this decisive step in defence of the rights, dignity, customs and ...

Pharmazz Inc. announced that U.S. Food and Drug Administration (FDA) has cleared the Company?s Investigational New Drug (IND) application to proceed with a pivotal Phase 3 clinical trial evaluating ...